Literature DB >> 19081819

Is there a need to identify new anti-emetic drugs?

Charles C Horn1.   

Abstract

Nausea and vomiting occur in a large number of disease conditions and as side effects of many drug treatments, including use of analgesics and anesthesia in surgery and chemotherapy in cancer treatment. Current anti-emetics provide relief from only some sources of vomiting, with more limited benefits for the control of nausea. Elucidation of forebrain pathways that generate nausea and brainstem circuitry controlling emesis are significant obstacles for the development of effective universal anti-nausea and anti-emetic treatments.

Entities:  

Year:  2007        PMID: 19081819      PMCID: PMC2597850          DOI: 10.1016/j.ddstr.2007.09.002

Source DB:  PubMed          Journal:  Drug Discov Today Ther Strateg        ISSN: 1740-6773


  36 in total

1.  Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology.

Authors:  R J Gralla; D Osoba; M G Kris; P Kirkbride; P J Hesketh; L W Chinnery; R Clark-Snow; D P Gill; S Groshen; S Grunberg; J M Koeller; G R Morrow; E A Perez; J H Silber; D G Pfister
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

Review 2.  Physiological basis and pharmacology of motion sickness: an update.

Authors:  B J Yates; A D Miller; J B Lucot
Journal:  Brain Res Bull       Date:  1998-11-15       Impact factor: 4.077

Review 3.  Treatment of nausea and vomiting: gaps in our knowledge.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Auton Neurosci       Date:  2006-08-24       Impact factor: 3.145

4.  Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus.

Authors:  F Okada; Y Torii; H Saito; N Matsuki
Journal:  Jpn J Pharmacol       Date:  1994-02

5.  American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

Authors:  Mark G Kris; Paul J Hesketh; Mark R Somerfield; Petra Feyer; Rebecca Clark-Snow; James M Koeller; Gary R Morrow; Lawrence W Chinnery; Maurice J Chesney; Richard J Gralla; Steven M Grunberg
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544

Review 6.  Selective phosphodiesterase 4 inhibitors in the treatment of allergy and inflammation.

Authors:  Victoria Boswell Smith; Domenico Spina
Journal:  Curr Opin Investig Drugs       Date:  2005-11

7.  A randomized, double-blind comparison of the NK1 antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting.

Authors:  Tong J Gan; Christian C Apfel; Anthony Kovac; Beverly K Philip; Neil Singla; Harold Minkowitz; Ashraf S Habib; Jennifer Knighton; Alexandra D Carides; Hong Zhang; Kevin J Horgan; Judith K Evans; Francasca C Lawson
Journal:  Anesth Analg       Date:  2007-05       Impact factor: 5.108

8.  Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.

Authors:  R Gralla; M Lichinitser; S Van Der Vegt; H Sleeboom; J Mezger; C Peschel; G Tonini; R Labianca; A Macciocchi; M Aapro
Journal:  Ann Oncol       Date:  2003-10       Impact factor: 32.976

9.  Suncus murinus: a new experimental model in emesis research.

Authors:  S Ueno; N Matsuki; H Saito
Journal:  Life Sci       Date:  1987-07-27       Impact factor: 5.037

Review 10.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Authors:  Paul L R Andrews; Charles C Horn
Journal:  Auton Neurosci       Date:  2006-03-23       Impact factor: 3.145

View more
  3 in total

1.  Musk shrews selectively bred for motion sickness display increased anesthesia-induced vomiting.

Authors:  Charles C Horn; Kelly Meyers; Nicholas Oberlies
Journal:  Physiol Behav       Date:  2013-11-14

2.  Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus).

Authors:  Bart C De Jonghe; Charles C Horn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

3.  The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.

Authors:  S Foth; S Meller; H Kenward; J Elliott; L Pelligand; H A Volk
Journal:  BMC Vet Res       Date:  2021-06-21       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.